No one's said Molnupiravir was similar to IVM.[/I]
I never said they did. There have been comments about Pfizer's tablet (Paxlovid) being repurposed Ivermectin though. I included Molnupiravir for interests sake and to show that all 3 are very different from each other.
As I mentioned in my original post, I also found it interesting that Merck are spending funds on developing Molnupiravir when many think they have a perfectly viable treatment in Ivermectin. And, as you pointed out in your post, developing the drug is not an easy task with the trialing attached to it, and therefore these funds that they are spending are likely to be a significant amount.
Last edited:





